Literature DB >> 17967146

A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television.

Wendy Macias1, Kartik Pashupati, Liza Stavchansky Lewis.   

Abstract

Over $4 billion is being spent on direct-to-consumer advertising (DTCA) of prescription drugs. Although the greatest proportion of this media budget is spent on television, relatively few studies have investigated the key issues of DTCA on television (DTCA-TV), including fair balance, FDA regulations and if information or appeals is focused on more. This study found that emotional and rational appeals were used to a similar degree in DTCA-TV. Print tends to be more informative than TV. After developing a four-tiered classification scheme (lawbreakers, bare minimums, DTC main pack/peloton and proactives), this study found that DTCA-TV ads are not doing a good job of meeting the FDA's fair balance requirement, particularly in presenting risk information in a comprehensible manner. Today's new active healthcare consumers often want to learn what issues are important to consider when investigating drugs and how to evaluate alternative courses of treatment. Given the proportion of money spent on television, the medical industry is correct to be concerned that education does not appear more important to DTCA advertisers.

Entities:  

Mesh:

Year:  2007        PMID: 17967146     DOI: 10.1080/10410230701626893

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  13 in total

1.  Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.

Authors:  Adrienne E Faerber; David H Kreling
Journal:  J Gen Intern Med       Date:  2014-01       Impact factor: 5.128

2.  Seniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.

Authors:  Jerry L Grenard; Visith Uy; José A Pagán; Dominick L Frosch
Journal:  Patient Educ Couns       Date:  2010-11-01

3.  Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Authors:  Robert A Bell; Laramie D Taylor; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2010-02-21

4.  Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study.

Authors:  Helen Sullivan; Vanessa Boudewyns; Amie O'Donoghue; Sandra Marshall; Pamela A Williams
Journal:  J Public Policy Mark       Date:  2017-09-01

5.  Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.

Authors:  Helen W Sullivan; Kathryn J Aikin; Jon Poehlman
Journal:  Health Commun       Date:  2017-11-10

6.  Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.

Authors:  Kristina Klara; Jeanie Kim; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2018-02-26       Impact factor: 5.128

7.  Mixed Messages, Mixed Outcomes: Exposure to Direct-to-Consumer Advertising for Statin Drugs is Associated with More Frequent Visits to Fast Food Restaurants and Exercise.

Authors:  Jeff Niederdeppe; Rosemary J Avery; Maxwell D Kellogg; Alan Mathios
Journal:  Health Commun       Date:  2016-07-18

8.  The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Molly Lynch; Mihaela Johnson; Christine Davis; Douglas J Rupert
Journal:  Med Decis Making       Date:  2019-10-04       Impact factor: 2.583

9.  Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use.

Authors:  Jeff Niederdeppe; Sahara Byrne; Rosemary J Avery; Jonathan Cantor
Journal:  J Gen Intern Med       Date:  2013-03-06       Impact factor: 5.128

10.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.